Discovering Potential COVID-19 Therapies using High Content Screening

Discovering Potential COVID-19 Therapies using High Content Screening

 

Summary

In this webinar, Professor Jonny Sexton discusses a pipeline, developed in the Sexton lab, for the quantitative high-throughput image-based screening of SARS-CoV-2 infection to identify potential antiviral mechanisms and allow selection of appropriate drug combinations to treat COVID-19. This webinar presents evidence that morphological profiling can robustly identify new potential therapeutics against SARS-CoV-2 infection as well as drugs that potentially worsen COVID-19 outcomes.

In this webinar, you will discover:

  • The machine learning approaches leveraged by the Sexton Lab to create an assay metric that accurately and robustly identifies features that predict antiviral efficacy and mechanism of action (MOA).
  • Several FDA-approved drugs and clinical candidates with a unique antiviral activity identified using this approach.
  • How lactoferrin inhibits viral entry and replication, enhances antiviral host cell response, and potentiates the effects of remdesivir and hydroxychloroquine.
  • How currently prescribed drugs that exacerbate viral infectivity were also identified.

 

Date and time

Wednesday, August 26th, 2020, 12 pm (EST) 9 am (PST) 5 pm (London)

 

Speaker

Jonny Sexton
Assistant Professor, Internal Medicine, Division of Gastroenterology and Hepatology
Assistant Professor, College of Pharmacy, Medicinal Chemistry
Faculty Lead, Michigan Institute for Clinical & Health Research, MICHR, Drug Repurposing

 

Related Products & Solutions

Benchtop System

The CQ1 provides the highest quality confocal images and extended live cell imaging in a space-saving benchtop design. 

High Content Analysis CellVoyager

Our high-content analysis (HCA) systems utilize powerful software to address a wide range of research applications from basic science to complex compound screening.

High-Throughput Screening

CellVoyager CV8000 is the most advanced high-content screening system. The improved built-in incubator lets you analyze extended live cell responses. With its expandability, 4 cameras, 5 lasers and an optional built-in pipettor, the system permits increasingly complex assay development and high-content screening.

Life Innovation

Through the use of measurement, control, information technology and life science, radically improve productivity across the entire value chain, from basic research to logistics and services.

Life Science

We have 30 years of experience in this life science field and will respond to customer's problem solving with cutting-edge solutions.

Top